Newbridge Financial Services Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12
| Closed | -$5 | – | 1254 |
|
|
2024
Q1 | $5 | Hold |
12
| – | – | ﹤0.01% | 1175 |
|
|
2023
Q4 | $9 | Hold |
12
| – | – | ﹤0.01% | 1113 |
|
|
2023
Q3 | $10 | Hold |
12
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q2 | $22 | Sell |
12
-1
| -8% | -$2 | ﹤0.01% | 1337 |
|
|
2023
Q1 | $46 | Hold |
13
| – | – | ﹤0.01% | 1380 |
|
|
2022
Q4 | $48 | Hold |
13
| – | – | ﹤0.01% | 1419 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 1510 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1564 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 1600 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1383 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1411 |
|
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 1214 |
|
|
2020
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 989 |
|
|
2020
Q3 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 941 |
|